Prenetics Global Ltd
PRE Nasdaq
SEC CIK 1876431
Follow Prenetics Global
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY24 | $30.6M | −$46.3M |
| FY23 | $21.7M | −$62.7M |
| FY22 | $13.2M | −$190.5M |
| FY21 | $12.5M | −$174M |
| FY20 | $65.2M | −$1.9M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY24 | 50.3% | −157.2% | −151.2% |
| FY23 | 40.6% | −238.7% | −288.5% |
| FY22 | 27.5% | −501.5% | −1446.8% |
| FY21 | 28.7% | −452.1% | −1388.4% |
| FY20 | 40.4% | −1.5% | −3% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY24 | −$29.9M |
| FY23 | −$14.1M |
| FY22 | $9.6M |
| FY21 | $4.9M |
| FY20 | −$5.7M |
| FY19 | - |
- Prenetics Global
- Healthcare median
Show the numbers
| Year | Prenetics Global | Healthcare median |
|---|---|---|
| FY24 | −151.2% | −47% |
| FY23 | −288.5% | −58% |
| FY22 | −1446.8% | −80.4% |
| FY21 | −1388.4% | −71.9% |
| FY20 | −3% | −62.2% |
| FY19 | - | −46.3% |